PharmaBlock Sciences (Nanjing), Inc. (300725.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap8.05B
Enterprise Value7.7B
P/E Ratio40.24
PEG Ratio-3.45
Price/Sales Ratio4.21
Price/Book Ratio1.55
Enterprise/Revenue4.11
Enterprise/EBITDA25.03

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.1
Operating Margin0.1
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.03

Income Statement

Revenue1.97B
Revenue/Share8.7
Gross Profit608.45M
EBITDA381.61M
Net Income183.74M
Diluted EPS0.88

Balance Sheet

Total Cash1.06B
Total Cash/Share4.56
Total Debt176.6M
Total Debt/Equity0.03
Current Ratio4.23
Book Value Per Share23.6

Price History

52-Week Change-23.98
52-Week High51.15
52-Week Low30.9
Moving Average 50 Days35.96
Moving Average 200 Days38.53

Statistics

Average Volume11.39M
Shares Outstanding232.97M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.28
Trailing Annual Dividend Yield0.76
Payout Ratio0.33
Last Split Factor13:10
Last Split DateApril 26, 2021
AD